Search Results | CountyCat

Catalog Search Results

Sort by

1) Medicare outpatient drugs: program payments should better reflect market prices

Author

United States. General Accounting Office

Series

Testimony volume GAO-02-531 T

Pub. Date

[2002]

Language

English

2) Promotional spending for prescription drugs

Author

Campbell, Sheila

Series

Economic and budget issue brief

Pub. Date

[2009]

Physical Description

1 online resource (8 pages) : illustrations.

Language

English

3) The cost of prescription drugs: examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate,...

Author

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions

Series

S. hrg volume 115-820

Pub. Date

2020.

Physical Description

iii, 41 pages ; 24 cm

Language

English

4) The complex web of prescription drug prices: hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC

Author

United States. Congress. Senate. Special Committee on Aging

Series

S. hrg volume 116-550
S. hrg volume 116-546
S. hrg volume 116-553

Pub. Date

2022.

Physical Description

3 volumes : illustrations ; 24 cm

Language

English

5) Medicare Drug Price Negotiation under the Inflation Reduction Act: industry responses and potential effects

Author

Hickey, Kevin J

Series

CRS report volume R47872

Pub. Date

2023-

Physical Description

1 online resource.

Language

English

6) The cost of prescription drugs: examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate,...

Author

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions

Series

S. hrg volume 115-820

Pub. Date

2020.

Physical Description

1 online resource (iii, 41 pages).

Language

English

7) Prescription drugs: overview of approaches to control prescription drug spending in federal programs : testimony before the Subcommittee on Federal Workforce, Postal Service, and the District of...

Author

Dicken, John E

Series

Testimony volume GAO-09-819T

Pub. Date

[2009]

Physical Description

1 online resource (14 pages).

Language

English

8) The complex web of prescription drug prices: hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC

Author

United States. Congress. Senate. Special Committee on Aging

Series

S. hrg volume 116-550
S. hrg volume 116-546
S. hrg volume 116-553

Pub. Date

2022.

Physical Description

1 online resource (3 volumes) : color illustrations.

Language

English

9) Strategies to reduce Medicaid drug expenditures

Author

United States. Department of Health and Human Services. Office of Inspector General

Pub. Date

[1991]

Physical Description

1 online resource (24 unnumbered pages) : illustrations.

Language

English

10) The role of pharmacy benefit managers in prescription drug markets: hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session

Author

United States. Congress. House. Committee on Oversight and Accountability

Pub. Date

2023.

Physical Description

volumes ; 24 cm

Language

English

11) Drug pricing in America: a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session

Author

United States. Congress. Senate. Committee on Finance

Series

S. hrg

Pub. Date

2019-

Physical Description

volumes : illustrations ; 24 cm

Language

English

12) TRICARE's 5th generation pharmacy contract: TPharm5

Author

Mendez, Bryce H. P

Series

Insight volume IN12053

Pub. Date

2022-

Physical Description

1 online resource.

Language

English

13) The role of pharmacy benefit managers in prescription drug markets: hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session

Author

United States. Congress. House. Committee on Oversight and Accountability

Pub. Date

2023.

Physical Description

1 online resource (volumes)

Language

English

14) Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019": scheduled for markup by the House Committee on Ways and Means on October 22, 2019

Pub. Date

[2019]

Physical Description

1 online resource (i, 9 pages)

Language

English

15) Prescription drug benefits: implications for beneficiaries of Medicare HMO use of formularies : report to congressional requesters

Author

United States. General Accounting Office

Pub. Date

[1999]

Physical Description

22 pages ; 28 cm

Language

English

16) Prescription drug benefits: impact of Medicare HMO's use of formularies on beneficiaries: testimony before the Special Committee on Aging, U.S. Senate

Author

United States. General Accounting Office

Series

Testimony volume GAO/T-HEHS-99-171

Pub. Date

1999.

Physical Description

1 online resource (7 pages).

Language

English

17) Cost containment of Medicaid HIV/AIDS drug expenditures

Author

United States. Department of Health and Human Services. Office of Inspector General

Pub. Date

2001.

Physical Description

1 online resource (iv, 42 pages) : illustrations.

Language

English

18) Third in series on medicare reform: laying the groundwork for a RX drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh...

Author

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health

Pub. Date

2001.

Physical Description

iii, 84 pages : illustrations ; 24 cm

Language

English

19) Pharmacy benefit managers: FEHBP plans satisfied with savings and services, but retail pharmacies have concerns : report to congressional requesters

Author

United States. General Accounting Office

Pub. Date

[1997]

Physical Description

24 pages : illustrations ; 28 cm

Language

English

20) DOD pharmacy benefits programreduced pharmacy costs resulting from the uniform formulary and manufacturer rebates]

Author

Dicken, John E

Pub. Date

[2007]

Physical Description

4 pages : digital, PDF file.

Language

English

Didn't find it?

Can't find what you are looking for? Consider suggesting a title. Submit Request

Navigation

Main Navigation

Filter Results

Narrow Your Results

Catalog Search Results

1) Medicare outpatient drugs: program payments should better reflect market prices

2) Promotional spending for prescription drugs

3) The cost of prescription drugs: examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate,...

4) The complex web of prescription drug prices: hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC

5) Medicare Drug Price Negotiation under the Inflation Reduction Act: industry responses and potential effects

6) The cost of prescription drugs: examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate,...

7) Prescription drugs: overview of approaches to control prescription drug spending in federal programs : testimony before the Subcommittee on Federal Workforce, Postal Service, and the District of...

8) The complex web of prescription drug prices: hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC

9) Strategies to reduce Medicaid drug expenditures

10) The role of pharmacy benefit managers in prescription drug markets: hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session

11) Drug pricing in America: a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session

12) TRICARE's 5th generation pharmacy contract: TPharm5

13) The role of pharmacy benefit managers in prescription drug markets: hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session

14) Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019": scheduled for markup by the House Committee on Ways and Means on October 22, 2019

15) Prescription drug benefits: implications for beneficiaries of Medicare HMO use of formularies : report to congressional requesters

16) Prescription drug benefits: impact of Medicare HMO's use of formularies on beneficiaries: testimony before the Special Committee on Aging, U.S. Senate

17) Cost containment of Medicaid HIV/AIDS drug expenditures

18) Third in series on medicare reform: laying the groundwork for a RX drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh...

19) Pharmacy benefit managers: FEHBP plans satisfied with savings and services, but retail pharmacies have concerns : report to congressional requesters

20) DOD pharmacy benefits programreduced pharmacy costs resulting from the uniform formulary and manufacturer rebates]

Didn't find it?